Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Mov Disord. 2022 Sep 3;37(11):2173–2183. doi: 10.1002/mds.29209

Figure 2.

Figure 2.

The relevance of Mendelian randomization studies in Parkinson disease. These studies did not find any association between transporters of uric acid and Parkinson disease, questioning the idea that low UA causes PD or contributes to its progression. However, the available studies cannot definitively confirm nor refute these causal associations between uric acid and PD, because they cannot exclude an impact of other possible molecules on PD (pleiotropy) and the impact of these transporters is biologically relatively small relative to other factors that may have a bigger impact on uric acid levels.